BRPI0810835A2 - Formulações de hidroquinona ansamicina - Google Patents

Formulações de hidroquinona ansamicina

Info

Publication number
BRPI0810835A2
BRPI0810835A2 BRPI0810835-8A BRPI0810835A BRPI0810835A2 BR PI0810835 A2 BRPI0810835 A2 BR PI0810835A2 BR PI0810835 A BRPI0810835 A BR PI0810835A BR PI0810835 A2 BRPI0810835 A2 BR PI0810835A2
Authority
BR
Brazil
Prior art keywords
anxamycin
hydroquinone
formulations
hydroquinone formulations
anxamycin hydroquinone
Prior art date
Application number
BRPI0810835-8A
Other languages
English (en)
Inventor
James L Wright
James R Porter
Original Assignee
Infinity Discovery Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Infinity Discovery Inc filed Critical Infinity Discovery Inc
Publication of BRPI0810835A2 publication Critical patent/BRPI0810835A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
BRPI0810835-8A 2007-04-12 2008-04-11 Formulações de hidroquinona ansamicina BRPI0810835A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91133007P 2007-04-12 2007-04-12
PCT/US2008/060063 WO2008128063A1 (en) 2007-04-12 2008-04-11 Hydroquinone ansamycin formulations

Publications (1)

Publication Number Publication Date
BRPI0810835A2 true BRPI0810835A2 (pt) 2015-06-16

Family

ID=39628966

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0810835-8A BRPI0810835A2 (pt) 2007-04-12 2008-04-11 Formulações de hidroquinona ansamicina

Country Status (10)

Country Link
US (1) US20080255080A1 (pt)
EP (1) EP2134338A1 (pt)
JP (1) JP2010523710A (pt)
CN (1) CN101677991A (pt)
AU (1) AU2008240179A1 (pt)
BR (1) BRPI0810835A2 (pt)
CA (1) CA2684211A1 (pt)
IL (1) IL201283A0 (pt)
MX (1) MX2009010808A (pt)
WO (1) WO2008128063A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1716119E (pt) 2003-12-23 2013-06-04 Infinity Discovery Inc Análogos de ansamicinas contendo benzoquinona para o tratamento do cancro
KR20110090925A (ko) * 2008-10-15 2011-08-10 인피니티 파마슈티컬스, 인코포레이티드 안사마이신 하이드로퀴논 조성물
CN115227692A (zh) * 2022-09-05 2022-10-25 中国医学科学院基础医学研究所 Reblastatin在制备治疗慢性惊厥的药物中的用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4261989A (en) * 1979-02-19 1981-04-14 Kaken Chemical Co. Ltd. Geldanamycin derivatives and antitumor drug
US4762857A (en) * 1986-05-30 1988-08-09 E. I. Du Pont De Nemours And Company Trehalose as stabilizer and tableting excipient
US5387584A (en) * 1993-04-07 1995-02-07 Pfizer Inc. Bicyclic ansamycins
US5932566A (en) * 1994-06-16 1999-08-03 Pfizer Inc. Ansamycin derivatives as antioncogene and anticancer agents
EP0833667A4 (en) * 1995-06-07 2001-11-21 Univ California STABILIZATION OF POLYNUCLEOTIDE COMPLEXES
MY120063A (en) * 1997-12-09 2005-08-30 Lilly Co Eli Stabilized teriparatide solutions
WO1999042834A2 (en) * 1998-02-18 1999-08-26 Theryte Limited Treating cancer
SI21369A (sl) * 2001-03-30 2004-06-30 The United States Of America, Represented By The Secretary, Geldanamicinski derivat in postopek zdravljenja raka z uporabo le-tega
US6872715B2 (en) * 2001-08-06 2005-03-29 Kosan Biosciences, Inc. Benzoquinone ansamycins
EP1472230B1 (en) * 2002-02-08 2009-06-17 Conforma Therapeutic Corporation Ansamycins having improved pharmacological and biological properties
PL207018B1 (pl) * 2002-06-21 2010-10-29 Novo Nordisk Helth Care Ag Kompozycja farmaceutyczna, sposób przygotowania stabilnego polipeptydu czynnika VII i zastosowanie polipeptydu czynnika VII
US20060019941A1 (en) * 2003-12-23 2006-01-26 Infinity Pharmaceuticals, Inc. Analogs of benzoquinone-containing ansamycins and methods of use thereof
PT1716119E (pt) * 2003-12-23 2013-06-04 Infinity Discovery Inc Análogos de ansamicinas contendo benzoquinona para o tratamento do cancro
US20070048323A1 (en) * 2004-02-20 2007-03-01 Rubin J P Antibody treatment of lipomatous tumors
US7608611B2 (en) * 2005-03-11 2009-10-27 The Regents Of The University Of Colorado Hsp90 inhibitors, methods of making and uses therefor
EP1906950A4 (en) * 2005-06-21 2008-09-24 Infinity Discovery Inc ANSAMYCIN FORMULATIONS AND METHODS OF USE
CN101360492A (zh) * 2005-12-01 2009-02-04 康福玛医药公司 含安莎霉素的组合物
PL2526771T3 (pl) * 2006-09-22 2017-06-30 Pharmacyclics Llc Inhibitory kinazy tyrozynowej Brutona

Also Published As

Publication number Publication date
US20080255080A1 (en) 2008-10-16
CA2684211A1 (en) 2008-10-23
JP2010523710A (ja) 2010-07-15
MX2009010808A (es) 2009-10-29
IL201283A0 (en) 2010-05-31
CN101677991A (zh) 2010-03-24
EP2134338A1 (en) 2009-12-23
WO2008128063A1 (en) 2008-10-23
AU2008240179A1 (en) 2008-10-23

Similar Documents

Publication Publication Date Title
NL301207I2 (nl) tezepelumab
NL301011I2 (nl) pegvaliase
BRPI0814188A2 (pt) Formulações
BRPI0814003A2 (pt) Formulações de anticorpo
BRPI0814252A2 (pt) Formulações de anticorpo
DK2068886T3 (da) Lipidholdige præparater
ES2527409T4 (es) Formulaciones de inhibidores de DPP IV
BRPI0820381A2 (pt) Formulações farmacêuticas
BRPI0821573A2 (pt) benzofuropirimidonas
ATE501136T1 (de) Imidazopyridinone
ATE514696T1 (de) Diphenyl-dihydro-imidazopyridinone
BRPI0811451A2 (pt) Exopolissacarídeo
BRPI0814519A2 (pt) Organopolissiloxano
DK2125048T3 (da) Præparat
BRPI0812840A2 (pt) 2-imidazolinas
AT505058A3 (de) Türschliesssystem
BRPI0815547A2 (pt) Depsipeptídeos cícliocos
BRPI0812994A2 (pt) Microbiocidas
DE602007007755D1 (de) Fußplatte
DE112008001216A5 (de) Magnetronplasmaanlage
BRPI0809653A2 (pt) Formulações líquidas de manoproteína
DE602008000912D1 (de) Schaltanlage
DE602008006131D1 (de) Schussfadeneintragdüse
CU20090155A7 (es) Macrolidos
DE102007038931A8 (de) Fadenlagennähwirkstoffe

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.